Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Journal of Computer-Aided Molecular Design

Quantum algorithm for protein-ligand docking sites identification in the interaction space

Ioannis Liliopoulos, Georgios D. Varsamis, Theodora Karamanidou, Christos Papalitsas, Grigorios Koulouras, Vassilios Pantazopoulos, Thanos G. Stavropoulos, Ioannis G. Karafyllidis

Published Jul 4, 2025• 8 citations
Publisher

Abstract

Over the past two decades, the development of novel drugs evolved into a high-demanding computational field. There is a constant and increasing need for advanced methods for determining protein-ligand binding in the drug design process. Even after the introduction and use of High-Performance Computers in drug design, fundamental problems and constraints have not been dealt with in a satisfactory manner. This is partially due to the fact that ligand docking in proteins is a quantum mechanical process. With the quantum computers available today, the question "Can quantum computers be used in drug design and how?" arises naturally. A novel quantum algorithm for protein-ligand docking site identification is presented here. In detail, the protein lattice model has been expanded to include protein-ligand interactions. Quantum state labelling for the interaction sites is introduced, and an extended and modified Grover quantum search algorithm is implemented to search for docking sites. This algorithm has been tested and executed on both a quantum simulator and a real quantum computer. The results show that the quantum algorithm can identify effectively docking sites. The quantum algorithm is highly scalable and well-suited for identifying docking sites within large proteins, poised to harness the potential of increased quantum bits in the future.

DOI
10.1007/s10822-025-00620-5

Related papers

Breaking the Bottleneck in Drug Screening... First Development of a Quantum Algorithm for Protein-Ligand Docking Identification

inquantio

A study published in the Journal of Computer-Aided Molecular Design presents the first innovative quantum algorithm for identifying the optimal docking sites where proteins and ligands bind during the drug design process. It expands the existing protein lattice model to fully include hydrogen bonding and hydrophobic interactions, introducing quantum state labelling for interaction sites and applying an extended and modified Grover quantum search algorithm. The algorithm was successfully verified on IBM's real 127-qubit quantum computers by applying error mitigation techniques (such as M3 and Pauli twirling), and it is expected to exponentially accelerate drug candidate screening for large proteins as hardware scales up in the future. [Quantum Biology Society] Even after the introduction of High-Performance Computers (HPC) into drug development, protein-ligand docking has faced fundamental computational limits with classical computing methods because it is inherently a complex quantum mechanical interaction process. In response to the question, "Can quantum computers be used in drug design and how?" raised alongside the rapid advancement of quantum computers today, a study titled "Quantum algorithm for protein-ligand docking sites identification in the interaction space," recently published in the international journal Journal of Computer-Aided Molecular Design, has provided a clear answer. An industry-academia joint research team consisting of Professor Ioannis G. Karafyllidis from the Democritus University of Thrace in Greece and researchers from the multinational pharmaceutical company Pfizer conducted this innovative study. ■ Combination of an Extended Lattice Model and Grover's Quantum Search Algorithm The researchers significantly expanded the previously used protein lattice model to fully encompass hydrogen bonding and hydrophobic interactions, which are key interactions between proteins and ligands. Within this expanded model, they introduced quantum state labelling for each interaction site and implemented an extended and modified form of Grover's quantum search algorithm. Simulation of the algorithm demonstrated that it can identify potential docking sites inside the target protein even within a massive interaction space, and evaluate the optimal binding positions much more efficiently and rapidly than classical computing tools through Euclidean distance calculations based on the quantum SWAP test. ■ Real Quantum Hardware Verification and Infinite Scalability Notably, this study did not stop at simulators but verified the algorithm's accuracy by running it directly on IBM's real 127-qubit quantum computers (such as ibm_brisbane). To overcome the hardware noise generated during this process, they successfully applied state-of-the-art quantum error mitigation techniques such as M3 (Matrix-free Measurement Mitigation), Pauli twirling, and dynamical decoupling. The most powerful asset of the newly developed quantum algorithm is its exceptional scalability. Thanks to this characteristic, the algorithm is perfectly suited for exploring binding sites within complex target proteins with massive molecular weights. By breaking the bottleneck of traditional drug discovery pipelines that required heavy computations, it is expected to serve as a revolutionary milestone that will exponentially explode the potential of drug candidate screening and molecular design as the number of available qubits increases with future hardware advancements. #QuantumAlgorithm #DrugScreening #ProteinLigandDocking #GroverAlgorithm #QuantumComputing #DrugDevelopment #MolecularDocking #QuantumBiology #Biophysics #KoreanQuantumBiologySociety https://www.researchgate.net/publication/393436574_Quantum_algorithm_for_protein-ligand_docking_sites_identification_in_the_interaction_space

•Jul 10, 2026•0 citations

Protein-Ligand Binding Energy Calculation Using Quantum Approximate Optimization Technique

Dassen Sathan, Shakuntala Baichoo

Drug discovery is a resource-intensive process that often requires years of research and incurs high computational costs. Although classical machine learning (ML) has enhanced aspects of this process, its scalability is constrained by the exponential complexity of molecular interactions. Quantum computing (QC), with its inherent capabilities of superposition and entanglement, presents a transformative opportunity to overcome these limitations. Here, we introduce a novel Quantum Approximate Optimization Algorithm (QAOA)-based framework designed to efficiently compute protein-ligand binding energies which is a pivotal metric in rational drug design and precision medicine. By reformulating the binding energy problem as a MaxCut optimization, our approach achieves remarkable accuracy, with deviations of only ± 0.5kcal/mol relative to established classical methods such as funnel metadynamics. Furthermore, we demonstrate the robustness of the algorithm across various ligand topologies and protein conformations, highlighting its potential for scalable quantumaccelerated drug screening. This study advances the application of near-term quantum algorithms in computational chemistry and lays the foundation for future QC-driven breakthroughs in biomedical research. Our findings underscore the feasibility of quantumenhanced drug discovery, offering a pathway to significantly reduce the development timelines and costs while improving therapeutic precision.

International Conference on Next Generation Computing Applications (NextComp)•Jul 1, 2026•0 citations

Quantum Computing in Drug Discovery: A Review of Foundations and Emerging Applications

Sandeep Kulkarni, Dr. Pushpalata S. Patil, Ravindra D Patil

Research Problem: The traditional methods of drug discovery are time-consuming, costly, and at times ineffective. There is a need for more novel approaches that can enhance the processes of discovering new drugs and developing them into usable products. Objective of the Paper: This paper aims to conduct a review of the literature and find how the application of quantum computing can change the way drugs are discovered and processed in practice. Process of Review: The review process involved a comprehensive examination of the available literature and recent advances in the application of quantum computing to drug discovery. The review encompassed major studies, theories, and case studies related to the subject matter, aiming to identify the current state and potential future directions of the domain. Insights of the Review: 1. Primary Building Blocks: With quantum computing, superposition, entanglement, and other principles can be utilised to enable complex computations to be performed at higher speeds using less time than traditional computers. 2. Quantum modelling: Quantum computers are expected to accurately model the interactions of various molecules, which could result in the identification of viable drug candidates. 3. Drug Discovery Processes: Quantum algorithms are capable of faster processing than traditional methods when it comes to solving optimisation problems, such as protein structure prediction and molecular docking, in drug design. 4. Limitations and Challenges: As great as the promise of quantum computing is, it has its limitations and challenges, including hardware limitations, error rates, and the need for specialised algorithms. 5. Future Developments: The ongoing development of quantum hardware and algorithms is expected to enhance the practical applications of quantum computing in drug discovery, enabling the quicker and more cost-effective creation of new drugs.

International Journal of Advanced Pharmaceutical Sciences and Research•Jun 27, 2025•2 citations

Quantum Assisted Drug Discovery in Human Beings

B S Anupama, Amrit S R, A Chetan Kumar

The large search space and the challenge of accurately simulating quantum-level molecular interactions are the fundamental causes of the delayed, complicated, and costly process of discovering new medications. The effectiveness of conventional computational techniques, including molecular docking and molecular dynamics, to assess molecular characteristics and provide highly accurate drug candidate predictions is constrained. This paper presents a Quantum-Assisted Drug Discovery Simulation framework that combines cutting-edge quantum computing algorithms, specifically the Quantum Approximate Optimization Algorithm (QAOA) and the Variational Quantum Eigensolver (VQE), with traditional molecular docking tools like RDKit and AutoDock. The system uses these quantum algorithms to perform very accurate Quantum Refinement on the most potential therapeutic protein poses found by classical identification. This hybrid approach seeks to optimize drug-protein interactions more quickly, speed up early-stage drug discovery, and create opportunities for less costly, more accurate medical research, even though a combination of quantum and classical calculations allows more accurate prediction of molecular energies and binding affinities.

International Conference on Knowledge Engineering and Communication Systems (ICKECS)•Apr 24, 2026•0 citations

Protein Folding and Drug Discovery Using Quantum Computing’s Grover’s Algorithm

Andrew Haverly, Shahram Rahimi

In this paper, we present a novel approach to protein folding and drug discovery leveraging Grover’s algorithm. Our protein folding methodology focuses on accurately determining the phi and psi angles to achieve optimal protein configurations, ensuring the system attains a low energy state. In drug discovery, our algorithm accommodates variable primary structures, incorporating a critical examination step for comprehensive analysis. Detailed simulations demonstrate the efficacy of our approach in identifying potential drug candidates with high accuracy. Enhancements to Grover’s algorithm are realized through the integration of the Assembly-ToQuantumCompiler, optimizing quantum circuit designs for increased efficiency. Additionally, we introduce the Quantum Binary Neural Network (QBNN) to improve search precision and computational performance. By combining quantum algorithms with advanced compilers and neural networks, we aim to revolutionize computational biology and accelerate drug discovery. These algorithms improve as quantum computers improve.

International Conference on Quantum Communications, Networking, and Computing (QCNC)•Mar 31, 2025•2 citations

Computational Analysis: Unveiling the Quantum Algorithms for Protein Analysis and Predictions

S. Bhuvaneswari, R. Deepakraj, Shabana Urooj +2 more

The study of protein-protein interactions (PPIs) and predicting the protein structure plays a critical role in understanding cellular processes and designing therapeutic interventions. In this research, we explore the application of quantum algorithms, specifically Grover’s algorithm, in improving the accuracy and efficiency of PPI prediction. By harnessing the inherent parallelism and quantum search capabilities of Grover’s algorithm, we aim to enhance the identification of interacting protein pairs from large-scale datasets. We demonstrate the effectiveness of using this algorithm through an extensive approach, comparing the performance of Grover’s algorithm with classical machine learning algorithms. Our results reveal that the quantum algorithm offers significant improvements in prediction accuracy, enabling the identification of previously undetected PPIs. Moreover, we discuss the advantages and limitations of using Grover’s algorithm in PPI prediction and provide insights into its potential for accelerating research in protein interaction networks. This research highlights the potential of quantum algorithms in advancing the field of bioinformatics and protein interaction analysis.

IEEE Access•Jan 1, 2023•14 citations
Over the past two decades, the development of novel drugs evolved into a high-demanding computational field. There is a constant and increasing need for advanced methods for determining protein-ligand binding in the drug design process. Even after the introduction and use of High-Performance Computers in drug design, fundamental problems and constraints have not been dealt with in a satisfactory manner. This is partially due to the fact that ligand docking in proteins is a quantum mechanical process. With the quantum computers available today, the question "Can quantum computers be used in drug design and how?" arises naturally. A novel quantum algorithm for protein-ligand docking site identification is presented here. In detail, the protein lattice model has been expanded to include protein-ligand interactions. Quantum state labelling for the interaction sites is introduced, and an extended and modified Grover quantum search algorithm is implemented to search for docking sites. This algorithm has been tested and executed on both a quantum simulator and a real quantum computer. The results show that the quantum algorithm can identify effectively docking sites. The quantum algorithm is highly scalable and well-suited for identifying docking sites within large proteins, poised to harness the potential of increased quantum bits in the future.
A study published in the Journal of Computer-Aided Molecular Design presents the first innovative quantum algorithm for identifying the optimal docking sites where proteins and ligands bind during the drug design process. It expands the existing protein lattice model to fully include hydrogen bonding and hydrophobic interactions, introducing quantum state labelling for interaction sites and applying an extended and modified Grover quantum search algorithm. The algorithm was successfully verified on IBM's real 127-qubit quantum computers by applying error mitigation techniques (such as M3 and Pauli twirling), and it is expected to exponentially accelerate drug candidate screening for large proteins as hardware scales up in the future. [Quantum Biology Society] Even after the introduction of High-Performance Computers (HPC) into drug development, protein-ligand docking has faced fundamental computational limits with classical computing methods because it is inherently a complex quantum mechanical interaction process. In response to the question, "Can quantum computers be used in drug design and how?" raised alongside the rapid advancement of quantum computers today, a study titled "Quantum algorithm for protein-ligand docking sites identification in the interaction space," recently published in the international journal Journal of Computer-Aided Molecular Design, has provided a clear answer. An industry-academia joint research team consisting of Professor Ioannis G. Karafyllidis from the Democritus University of Thrace in Greece and researchers from the multinational pharmaceutical company Pfizer conducted this innovative study. ■ Combination of an Extended Lattice Model and Grover's Quantum Search Algorithm The researchers significantly expanded the previously used protein lattice model to fully encompass hydrogen bonding and hydrophobic interactions, which are key interactions between proteins and ligands. Within this expanded model, they introduced quantum state labelling for each interaction site and implemented an extended and modified form of Grover's quantum search algorithm. Simulation of the algorithm demonstrated that it can identify potential docking sites inside the target protein even within a massive interaction space, and evaluate the optimal binding positions much more efficiently and rapidly than classical computing tools through Euclidean distance calculations based on the quantum SWAP test. ■ Real Quantum Hardware Verification and Infinite Scalability Notably, this study did not stop at simulators but verified the algorithm's accuracy by running it directly on IBM's real 127-qubit quantum computers (such as ibm_brisbane). To overcome the hardware noise generated during this process, they successfully applied state-of-the-art quantum error mitigation techniques such as M3 (Matrix-free Measurement Mitigation), Pauli twirling, and dynamical decoupling. The most powerful asset of the newly developed quantum algorithm is its exceptional scalability. Thanks to this characteristic, the algorithm is perfectly suited for exploring binding sites within complex target proteins with massive molecular weights. By breaking the bottleneck of traditional drug discovery pipelines that required heavy computations, it is expected to serve as a revolutionary milestone that will exponentially explode the potential of drug candidate screening and molecular design as the number of available qubits increases with future hardware advancements. #QuantumAlgorithm #DrugScreening #ProteinLigandDocking #GroverAlgorithm #QuantumComputing #DrugDevelopment #MolecularDocking #QuantumBiology #Biophysics #KoreanQuantumBiologySociety https://www.researchgate.net/publication/393436574_Quantum_algorithm_for_protein-ligand_docking_sites_identification_in_the_interaction_space
Drug discovery is a resource-intensive process that often requires years of research and incurs high computational costs. Although classical machine learning (ML) has enhanced aspects of this process, its scalability is constrained by the exponential complexity of molecular interactions. Quantum computing (QC), with its inherent capabilities of superposition and entanglement, presents a transformative opportunity to overcome these limitations. Here, we introduce a novel Quantum Approximate Optimization Algorithm (QAOA)-based framework designed to efficiently compute protein-ligand binding energies which is a pivotal metric in rational drug design and precision medicine. By reformulating the binding energy problem as a MaxCut optimization, our approach achieves remarkable accuracy, with deviations of only ± 0.5kcal/mol relative to established classical methods such as funnel metadynamics. Furthermore, we demonstrate the robustness of the algorithm across various ligand topologies and protein conformations, highlighting its potential for scalable quantumaccelerated drug screening. This study advances the application of near-term quantum algorithms in computational chemistry and lays the foundation for future QC-driven breakthroughs in biomedical research. Our findings underscore the feasibility of quantumenhanced drug discovery, offering a pathway to significantly reduce the development timelines and costs while improving therapeutic precision.
Research Problem: The traditional methods of drug discovery are time-consuming, costly, and at times ineffective. There is a need for more novel approaches that can enhance the processes of discovering new drugs and developing them into usable products. Objective of the Paper: This paper aims to conduct a review of the literature and find how the application of quantum computing can change the way drugs are discovered and processed in practice. Process of Review: The review process involved a comprehensive examination of the available literature and recent advances in the application of quantum computing to drug discovery. The review encompassed major studies, theories, and case studies related to the subject matter, aiming to identify the current state and potential future directions of the domain. Insights of the Review: 1. Primary Building Blocks: With quantum computing, superposition, entanglement, and other principles can be utilised to enable complex computations to be performed at higher speeds using less time than traditional computers. 2. Quantum modelling: Quantum computers are expected to accurately model the interactions of various molecules, which could result in the identification of viable drug candidates. 3. Drug Discovery Processes: Quantum algorithms are capable of faster processing than traditional methods when it comes to solving optimisation problems, such as protein structure prediction and molecular docking, in drug design. 4. Limitations and Challenges: As great as the promise of quantum computing is, it has its limitations and challenges, including hardware limitations, error rates, and the need for specialised algorithms. 5. Future Developments: The ongoing development of quantum hardware and algorithms is expected to enhance the practical applications of quantum computing in drug discovery, enabling the quicker and more cost-effective creation of new drugs.
The large search space and the challenge of accurately simulating quantum-level molecular interactions are the fundamental causes of the delayed, complicated, and costly process of discovering new medications. The effectiveness of conventional computational techniques, including molecular docking and molecular dynamics, to assess molecular characteristics and provide highly accurate drug candidate predictions is constrained. This paper presents a Quantum-Assisted Drug Discovery Simulation framework that combines cutting-edge quantum computing algorithms, specifically the Quantum Approximate Optimization Algorithm (QAOA) and the Variational Quantum Eigensolver (VQE), with traditional molecular docking tools like RDKit and AutoDock. The system uses these quantum algorithms to perform very accurate Quantum Refinement on the most potential therapeutic protein poses found by classical identification. This hybrid approach seeks to optimize drug-protein interactions more quickly, speed up early-stage drug discovery, and create opportunities for less costly, more accurate medical research, even though a combination of quantum and classical calculations allows more accurate prediction of molecular energies and binding affinities.
In this paper, we present a novel approach to protein folding and drug discovery leveraging Grover’s algorithm. Our protein folding methodology focuses on accurately determining the phi and psi angles to achieve optimal protein configurations, ensuring the system attains a low energy state. In drug discovery, our algorithm accommodates variable primary structures, incorporating a critical examination step for comprehensive analysis. Detailed simulations demonstrate the efficacy of our approach in identifying potential drug candidates with high accuracy. Enhancements to Grover’s algorithm are realized through the integration of the Assembly-ToQuantumCompiler, optimizing quantum circuit designs for increased efficiency. Additionally, we introduce the Quantum Binary Neural Network (QBNN) to improve search precision and computational performance. By combining quantum algorithms with advanced compilers and neural networks, we aim to revolutionize computational biology and accelerate drug discovery. These algorithms improve as quantum computers improve.
The study of protein-protein interactions (PPIs) and predicting the protein structure plays a critical role in understanding cellular processes and designing therapeutic interventions. In this research, we explore the application of quantum algorithms, specifically Grover’s algorithm, in improving the accuracy and efficiency of PPI prediction. By harnessing the inherent parallelism and quantum search capabilities of Grover’s algorithm, we aim to enhance the identification of interacting protein pairs from large-scale datasets. We demonstrate the effectiveness of using this algorithm through an extensive approach, comparing the performance of Grover’s algorithm with classical machine learning algorithms. Our results reveal that the quantum algorithm offers significant improvements in prediction accuracy, enabling the identification of previously undetected PPIs. Moreover, we discuss the advantages and limitations of using Grover’s algorithm in PPI prediction and provide insights into its potential for accelerating research in protein interaction networks. This research highlights the potential of quantum algorithms in advancing the field of bioinformatics and protein interaction analysis.